SCHEMBL5457225

SCHEMBL5457225

O=C(O)c1ccc(COc2ccc3cc(-c4ccc(-c5ccccc5)n4-c4ccccc4)ccc3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.51
NR4A1 P22736 1/20 0.51
NR4A3 Q92570 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 1/20 0.50
P2RY14 Q15391 1/20 0.50
MRGPRX4 Q96LA9 1/20 0.49
MDM2 Q00987 1/20 0.48
NPC1 O15118 3/20 0.48
MAPT P10636 2/20 0.48
SRD5A2 P31213 2/20 0.48
RXRA P19793 3/20 0.47
RXRB P28702 3/20 0.47
RXRG P48443 3/20 0.47
PTGES O14684 2/20 0.47
ALOX5 P09917 2/20 0.47
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
PLA2G4B P0C869 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451074 0.89 KDM4E (0.53) SMN1; SMN2NPC1MAPTALOX5ALDH1A1
SCHEMBL5446278 0.81 PTPN7 (0.58) NR4A1MAPTALDH1A1
SCHEMBL5455835 0.80 NR4A2 (0.48) NR4A2NR4A1NR4A3P2RY14MRGPRX4
SCHEMBL1756343 0.76 NR4A2 (0.81) NR4A2NR4A1NR4A3SMN1; SMN2NPC1
SCHEMBL5582767 0.76 NR4A2 (0.81) NR4A2NR4A1NR4A3SMN1; SMN2NPC1
SCHEMBL2324669 0.76 NR4A1 (0.49) NR4A2NR4A1NR4A3SMN1; SMN2TSHR
SCHEMBL5921632 0.75 MRGPRX4 (0.76) NR4A2NR4A1NR4A3SMN1; SMN2TSHR
SCHEMBL5447528 0.74 PPARG (0.63)
SCHEMBL6342568 0.74 NR4A2 (0.71) NR4A2NR4A1NR4A3SMN1; SMN2TSHR
SCHEMBL5448815 0.74 ADORA2A (0.39) SMN1; SMN2MAPTALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM WYETH (US) 2007-05-31 US claimed
EP-1781641-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS Wyeth (US) 2007-05-09 EP claimed
US-7186749-B2 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2007-03-06 US claimed
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2006-03-09 US claimed
WO-2006023864-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS WYETH (US) 2006-03-02 WO claimed
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM WYETH (US) 2007-05-31 US disclosed
EP-1781641-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS Wyeth (US) 2007-05-09 EP disclosed
US-7186749-B2 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2007-03-06 US disclosed
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2006-03-09 US disclosed
WO-2006023864-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM SERPINE1, SERPINC1, SERPINB1 NR4A2 3109/4885NR4A1 3555/4885NR4A3 3019/4885
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them SERPINE1, SERPINC1, SERPINB1 NR4A2 3109/4885NR4A1 3555/4885NR4A3 3019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.